Zdrowie i gospodarka · 23/09/1996

FDA Approves Neopath's AutoPap 300 QC System for Hematology Devices

The US Food and Drug Administration (FDA) has approved Neopath, Inc.'s application for premarket approval of the AutoPap 300 QC System, a quality control system for hematology devices, following the recommendation of the Hematology and Pathology Devices Panel. The approval was notified to Neopath on September 29, 1995.